SMILE: enrollment has resumed

Tags: , | April 5th, 2018

We are pleased to announce that enrollment in the SMILE study has recommenced. 3 new participants have recently been recruited in the clinical trial: 2 in Porto, Portugal and 1 in Zurich, Switzerland.

SMILE is a multicentre randomised study evaluating safety and antiviral effect of a once daily integrase inhibitor administered with Darunavir/Ritonavir compared to standard of care among HIV-1 infected, virologically suppressed paediatric participants.

PENTA is sponsor of this study, with 300 children due to be enrolled from about 30 sites from 10 countries.


We would like to update you on our recent activities